Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 22, 2016
70 pages — Published Sep 22, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Rusnano Corporation (Rusnano) is an open joint stock company which develops Russian nanotechnology industry through co-investing in nanotechnology projects. It offers its service for a business entity and for non-commercial organization. The company's services include business structuring, co-financing, developing, control and investment of business entities. Its non-commercial organization services include management of nanotechnology centers, engineering companies, certification support, metrology, education, improving legislation, popularizing nanotechnology and infrastructure, among others.

Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary

  
Source:
Document ID
GDPH370852D
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Rusnano Corporation, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
Rusnano Corporation, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
Rusnano Corporation, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
Rusnano Corporation, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201692
Rusnano Corporation, Medical Devices Deals, 2010 to YTD 2016111
Rusnano Corporation, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016125
Rusnano Corporation, Pharmaceuticals &Healthcare, Deal Details1750
  Venture Financing171
    Solix Biosystems Vostok Raises Funds through Venture Financing171
    Tragara Pharma Raises USD13 Million in Series C Financing182
    Syndax Pharma Raises USD80 Million in Series C Financing202
    Selecta Biosciences Raises More than USD20 Million in Venture Financing222
    Clearside Biomedical Raises USD16 Million in Series B Venture Financing242
    Aldea Pharma Raises USD24 Million in Series B Venture Financing262
    Bioptix Raises USD1.4 Million in Venture Financing281
    Epic Sciences Raises USD30 Million in Series C Venture Financing292
    NovaDigm Therapeutics Raises US$14 Million In Series B Financing312
    Tragara Pharma Raises US$12 Million In Extended Series B Financing332
    Syndax Pharma Raises US$27 Million In Series B Venture Financing352
    Lithera Raises US$35.6 Million In Series C Financing372
    Marinus Pharma Raises US$21 Million In Series C Financing392
    Regado Biosciences Raises US$51 Million In Series E Financing412
    CoDa Therapeutics Raises Additional US$20 Million In Series B Financing432
    Selecta Biosciences Secures US$47 Million In Series D Financing Round452
    Bind Biosciences Secures US$35 Million In Series D Financing Round473
    Bioptix Diagnostics Raises US$9 Million In Series B Financing501
  Partnerships511
    Domain Associates Forms Joint Venture With Rusnano511
    Rusnano, Human Stem Cells Institute, Pharmsynthez, Cryonix, And FDS Pharma Form SynBio522
    RUSNANO Enters Into Joint Venture Agreement With NEARMEDIC PLUS541
    Cleveland BioLabs Forms Joint Venture With RUSNANO552
    Celtic Pharma Forms Joint Venture With Russian Corporation Of Nanotechnologies572
    Rusnano Enters into Joint Venture Agreement with Epidbiomed591
    Chemrar Enters Into Joint Venture Agreement With Rusnano601
    MP Biomedicals Enters Into Co-Development Agreement With RUSNANO611
    MP Biomedicals Enters Into An Agreement With RUSNANO621
  Equity Offering631
    Farmsintez to Raise USD47.9 Million in Private Placement of Additional Shares631
    Farmsintez to Raise USD66.6 Million in Private Placement of Shares641
  Acquisition651
    Rusnano Acquires Minority Stake In Pharmsynthez For US$26.1 Million651
    IPG Photonics Acquires Remaining 22.5% Stake In NTO IRE-Polus From Rusnano For US$55.4 Million661
Rusnano Corporation - Key Competitors671
Key Employees681
Locations And Subsidiaries691
  Head Office691
  Other Locations &Subsidiaries691
Appendix701
  Methodology701
  About GlobalData701
  Contact Us701
  Disclaimer701

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Rusnano-Corporation-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23513>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Rusnano Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Rusnano-Corporation-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23513>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research